Dudediligence.

KALA BIO, Inc

KALANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$259,289

9 notices · 340,567 sh

Oct 2025 to Oct 2026

Reported ·

$248,725

6 sales · 0 buys

Oct 2025 to Sep 2026

The two figures cover different periods.

None of the 6 reported sales carry the 10b5-1 box. Together they are 1.57% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-03-17: ANDREW I KOVEN, Form 1442026-03-12: Howard B Rosen, Form 1442026-03-12: CHARLES D MYERS, Form 1442025-10-23: MARK IWICKI, Form 1442025-10-23: MARY REUMUTH, Form 1442025-10-22: MARY REUMUTH, Form 1442025-10-22: R K BRAZZELL, Form 1442025-10-22: TODD M BAZEMORE, Form 1442025-10-22: DARIUS KHARABI, Form 1442025-10-22: Brazzell Romulus K, sold2025-10-22: Bazemore Todd, sold2025-10-22: Reumuth Mary, sold2025-10-22: Kharabi Darius, sold2025-10-23: Iwicki Mark T, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-03-17ANDREW I KOVEN, Director$3,816
14,466 shno plan dateno Form 4 on file144 ↗
2026-03-12Howard B Rosen, Director$3,975
13,576 shno plan dateno Form 4 on file144 ↗
2026-03-12CHARLES D MYERS, Director$2,858
9,112 shno plan dateno Form 4 on file144 ↗
2025-10-23MARK IWICKI, Director$125,185
154,894 shno plan date144 ↗
Form 4, 2025-10-24: sold 154,894 at $0.81 Form 4 ↗
2025-10-23MARY REUMUTH, CHIEF FINANCIAL OFFICER$793
967 shno plan dateno Form 4 on file144 ↗
2025-10-22MARY REUMUTH, CHIEF FINANCIAL OFFICER$26,728
32,230 shno plan date144 ↗
Form 4, 2025-10-24: sold 33,197 at $0.83 Form 4 ↗
2025-10-22R K BRAZZELL, SEE REMARKS$38,964
46,748 shno plan date144 ↗
Form 4, 2025-10-24: sold 46,748 at $0.83 Form 4 ↗
2025-10-22TODD M BAZEMORE, Officer$39,686
47,768 shno plan date144 ↗
Form 4, 2025-10-24: sold 47,768 at $0.83 Form 4 ↗
2025-10-22DARIUS KHARABI, CHIEF BUSINESS OFFICER$17,284
20,806 shno plan date144 ↗
Form 4, 2025-10-24: sold 20,806 at $0.83 Form 4 ↗